
BioLife Solutions BLFS
$ 22.29
-1.59%
Quarterly report 2025-Q3
added 11-06-2025
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
46.1 M |
Market Cap[1] |
$ 1.03 B |
EBITDA (LTM) |
$ -17.1 M |
P/E (LTM) |
-61.49 |
P/S (LTM) |
10.61 |
EPS (LTM) |
-0.37 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Becton, Dickinson and Company
BDX
|
$ 180.73 | 5.23 % | $ 52 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 22.24 | 1.32 % | $ 11.3 B | NYSE,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 9.96 | 1.22 % | $ 201 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 79.01 | -1.83 % | $ 40.4 B | NYSE | ||
|
iRhythm Technologies
IRTC
|
$ 151.24 | -0.64 % | $ 4.72 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 7.59 | -0.26 % | $ 157 M | NYSE American | ||
|
AtriCure
ATRC
|
$ 33.2 | -12.25 % | $ 1.56 B | Nasdaq Global Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
electroCore
ECOR
|
$ 5.31 | -0.93 % | $ 29.3 K | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 86.9 | -1.22 % | $ 1.95 B | Nasdaq Global Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 11.24 | 1.95 % | $ 459 M | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 82.81 | 1.51 % | $ 16.5 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 57.68 | -3.02 % | $ 2.9 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 0.55 | -8.49 % | $ 23.3 M | Nasdaq Global Market | ||
|
Glaukos Corporation
GKOS
|
$ 109.2 | -3.39 % | $ 5.29 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 147.83 | -3.52 % | $ 3.61 B | Nasdaq Global Select Market,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.81 | - | $ 209 M | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.57 | -2.13 % | $ 208 M | Nasdaq Capital Market | ||
|
Masimo Corporation
MASI
|
$ 135.1 | 0.74 % | $ 7.2 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 495.47 | 0.06 % | $ 177 B | Nasdaq Global Select Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 81.21 | -1.23 % | $ 4.73 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 2.06 | -1.67 % | $ 166 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 1.99 | -2.69 % | $ 20.3 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 4.08 | 4.88 % | $ 42.4 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.26 | 1.32 % | $ 20.7 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 248.18 | 1.89 % | $ 18.1 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.76 | -1.26 % | $ 2.8 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 29.97 | -0.66 % | $ 5.16 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 38.98 | 4.41 % | $ 128 M | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 25.7 | 7.44 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Repligen Corporation
RGEN
|
$ 139.68 | -2.37 % | $ 7.78 M | Nasdaq Global Select Market,SPB | ||
|
ResMed
RMD
|
$ 259.03 | -1.71 % | $ 37.8 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 243.7 | -0.32 % | $ 24 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 4.33 % | $ 20.7 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 17.43 | 0.75 % | $ 856 M | Nasdaq Global Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 107.04 | 1.11 % | $ 5.01 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 64.31 | -0.31 % | $ 233 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.